If you liked this article you might like

Biotechs Bolstered on 21st Century Cures Passage
Mallinckrodt Beats Estimates, Issues Downbeat Guidance
Mallinckrodt Shares Tank, Despite Better-Than-Expected Earnings
Healthcare Stocks Help Nasdaq Reach New Heights